MedPath

MemoGut effect on IBS

Phase 2
Conditions
Irritable bowel syndrome.
Irritable bowel syndrome
Registration Number
IRCT201402089256N3
Lead Sponsor
Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
84
Inclusion Criteria

patients with IBS; age older than 18 years old.
Exclusion criteria: using other medications; pregnancy; incomplete medication; participants tend to exit from study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of symptoms. Timepoint: Baseline, 1 and 3 months after baseline. Method of measurement: Farsi and valid IBS-SSS questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath